|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase I clinical trial to evaluate the safety of a multiclade recombinant adenoviral vector HIV-1 vaccine adminstered to healthy, HIV-1 uninfected, adult participants who received DNA plasmid vaccine or placebo in the HVTN 052 clinical trial
HVTN 057 is a Phase I clinical trial to evaluate the safety and immunogenicity of a VRC-HIVADV014-00-VP (rAd5) boost given to participants who received VRC-HIVDNA009-00-VP (DNA) or placebo in HVTN 052.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.